Valeant shares get lift after it pays down extra $220-million from asset sales

Short resume:

pharmaceuticals
70%
shares
70%
debt
60%
subscribe
50%

Valeant Pharmaceuticals shares got a lift Monday after the drugmaker announced it had trimmed its hefty debt by an extra $220-million (U.
Source The Globe and Mail
Read More…

More News

Be the first to comment

Leave a Reply

Your email address will not be published.


*